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Abstract: 
Manganese (Mn) is an essential trace element, but overexposure is characterized by Parkinson's like symptoms 
in extreme cases. Previous studies have shown that Mn accumulation is exacerbated by dietary iron deficiency 
(ID) and disturbances in norepinephrine (NE) have been reported. Because behaviors associated with Mn 
neurotoxicity are complex, the goal of this study was to examine the effects of Mn exposure and ID-associated 
Mn accumulation on NE uptake in synaptosomes, extracellular NE concentrations, and expression of NE 
transport and receptor proteins. Sprague-Dawley rats were assigned to four dietary groups: control (CN; 35 mg 
Fe/kg diet), iron-deficient (ID; 6 mg Fe/kg diet), CN with Mn exposure (via the drinking water; 1 g Mn/L) 
(CNMn), and ID with Mn (IDMn) . 
3
H-NE uptake decreased significantly (R = -0.753, p=0.001) with increased 
Mn concentration in the locus coeruleus, while decreased Fe was associated with decreased uptake of 
3
H-NE in 
the caudate putamen (R = 0.436, p = 0.033) and locus coeruleus (R = 0.86; p < 0.001). Extracellular 
concentrations of NE in the caudate putamen were significantly decreased in response to Mn exposure and ID 
(p < 0.001). A diverse response of Mn exposure and ID was observed on mRNA and protein expression of NE 
transporter (NET) and α2 adrenergic receptor. For example, elevated brain Mn and decreased Fe caused an 
approximate 50% decrease in NET and α2 adrenergic receptor protein expression in several brain regions, with 
reductions in mRNA expression also observed. These data suggest that Mn exposure results in a decrease in NE 
uptake and extracellular NE concentrations via altered expression of transport and receptor proteins. 
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Article: 
1. Introduction 
An essential trace element and a cofactor for several enzymes (Hurley and Keen, 1987), manganese (Mn) is 
responsible for proper immune function, regulation of metabolism, reproduction, digestion, bone growth, and 
blood clotting (see review by Aschner et al., 2005). However, neurotoxicity is known to result from exposure to 
high concentrations of Mn. Known as manganism, Mn neurotoxicity is associated with the accumulation of Mn 
in iron-rich, dopaminergic regions of the brain, specifically areas of the basal ganglia (Aschner et al., 2005). 
Initially, manganism is characterized by a psychiatric disorder resembling schizophrenia, an anxiety disorder 
which may involve the noradrenergic system (Yamamoto and Hornykiewicz, 2004), and shares similarities with 
several clinical disorders, in particular Parkinson's disease (Pal et al., 1999). Most often, Mn neurotoxicity 
arises from chronic occupational exposure of welders, miners, and steel workers to high levels of airborne Mn 
particulates (Pal et al., 1999; Mergler et al., 1994), though cases from exposure to contaminated drinking water 
have been reported as well (Wasserman et al., 2006; Kondakis et al., 1989). 
 
It has become clear that iron deficiency (ID) is a risk factor for Mn accumulation (Davis et al., 1992; Erikson et 
al., 2002; Finley, 1999; Kwik-Uribe et al., 2000). Affecting more than 2 billion individuals worldwide 
(WHO/UNICEF/UNU, 2006), ID is associated with alterations in cognition and behavior (Beard, 2001), 
potentially disturbing neurochemistry via the facilitation of Mn accumulation in the brain, as iron (Fe) status 
may affect absorption of Mn, regardless of Mn concentrations in the body (Chandra and Shukla, 1976; Shukla 
et al., 1976).  
 
Manganese most likely competes with Fe for transport via divalent metal transporter 1 (DMT-1) (Gunshin et al., 
1997; Aschner et al., 2005), a transporter of various divalent metals. Increased expression of DMT-1 mRNA in 
the brain has been shown in cases of ID (Gunshin et al., 2001; Burdo et al., 1999), and this protein has recently 
become of interest as a potential transporter for Mn across the blood-brain barrier (Garrick et al., 2003; Roth 
and Garrick, 2003). In the blood, the majority of Mn is bound to albumin, with a small fraction bound to 
transferrin (Aschner et al., 2005). While most research has focused on the effects of Mn neurotoxicity on the 
metabolism of dopamine (DA) due to locomotor effects, alterations in the biology of other neurotransmitters 
such as norepinephrine (NE) have been noted (Table 1) (Autissier et al., 1982; Seth and Chandra, 1984; Struve 
et al., 2007). 
 
Norepinephrine, a neuromodulatory neurotransmitter derived from DA, exerts its effects via G-protein linked 
receptors and is associated with motivational behaviors and alertness, as well as locomotion and autonomic 
functions (Troadec et al., 2001). The locus coeruleus, a small area of the pons, is a major nucleus of NE 
expression, containing approximately half of the noradrenergic neurons in the brain (Andrade and Aghajanian, 
1984). Projecting fibers throughout the forebrain and cerebellum, the locus coeruleus plays a role in mediating 
stress and anxiety, modulation of the nigrostriatal pathway, and is affected by neuronal loss during idiopathic 
Parkinson's disease (Marien et al., 2004). Experimental lesioning of the locus coeruleus has been shown to 
exacerbate the pathology and symptomology in animal models of Parkinson's disease (Rommelfanger and 
Weinshenker, 2007). 
 
 
 
 
A recent study by Struve et al. (2007) found a marginal increase in NE tissue concentrations following Mn 
exposure via inhalation in rhesus monkeys. In earlier studies, varying alterations of tissue NE concentrations 
were identified in animal models of Mn exposure (see Table 1 for summary). Manganese has also been shown 
to inhibit NE uptake in a dose-dependent manner in synaptosomes isolated from the forebrain of Wistar rats 
(Lai et al., 1982), which could potentially lead to alterations in extracellular NE concentrations. A more recent 
study (Beard et al., 2006) examined the effects of Fe depletion on the expression of NET in PC12 cells and rat 
brain tissue. Those cells treated with desferrioxamine, an iron-chelating agent, exhibited a dose-dependent 
decrease in 3H-NE uptake that correlated with a decrease in NET protein levels. Attenuated NET protein 
expression in the brain during ID has been reported as well (Burhans et al., 2005); however, the exact role of 
NET during Mn exposure and ID still remains to be fully elucidated. 
 
Based upon previous data from our lab showing alterations in GABA biology as a result of dietary Mn exposure 
and ID (Anderson et al., 2007; 2008), coupled with the knowledge that behaviors associated with Mn 
neurotoxicity may relate to NE metabolism and gaps remaining concerning the effects of Mn exposure on NE 
biology, we hypothesize that dietary Mn exposure and ID-associated Mn accumulation could potentially lead to 
a decrease in NE uptake, leading to changes in the concentration of extracellular NE, most likely due to altered 
NE transporter and/or receptor expression.  
 
 
 
 
To examine this hypothesis, we developed this study: 1.) to establish the effects of dietary Mn exposure and ID-
associated Mn accumulation on 
3
H-NE uptake and in the neuromodulatory extracellular concentrations of NE; 
and 2.) to examine alterations in the protein and mRNA expression of the transport and receptor proteins of NE 
resulting from dietary Mn exposure and ID, which may provide insight into neurodegenerative processes where 
metal toxicity is implicated. 
 
2. Results 
2.1.Plasma manganese and iron 
Plasma Mn concentrations were significantly increased in those animals receiving Mn supplementation versus 
those animals receiving deionized water alone (p = 0.02) (Fig. 1A), as previously reported (Anderson et al., 
2008). A significant decrease in plasma Fe concentrations was observed in animals receiving the ID diet versus 
the CN diet (p = 0.007) (Fig. 1B). 
 
2.2.Brain manganese and iron 
As previously reported, Mn concentration was significantly increased in the Mn-exposure group versus those 
animals that did not receive Mn supplementation in all brain regions (p < 0.05) (Fig. 2A). A heterogeneous 
response was observed in the brain in regard to Fe levels, with a general decrease in Fe concentration in those 
animals receiving the ID diet versus animals receiving the CN diet, though the only significant decrease was 
seen in the globus pallidus (p < 0.05) (Fig. 2B). The Fe:Mn ratio is reported in Fig. 2C, illustrating a clear effect 
of Mn exposure on Fe homeostasis. 
 
2.3. In vitro studies 
Iron level was associated with a significant decrease in 
3
H-NE uptake in synaptosomes isolated from the 
caudate putamen after 6 weeks of dietary intervention (R = 0.436; p = 0.033) (Fig. 3B). No significant 
association was observed between Mn exposure and 
3
H-NE uptake in the caudate putamen (Fig. 3A). Increased 
Mn concentration was associated with a significant decrease in 
3
H-NE uptake in synaptosomes isolated from the 
locus coeruleus at 6 weeks (R = -0.753; p = 0.001) (Fig. 3C). Iron level was associated with a significant 
decrease in 
3
H-NE uptake in the locus ceruleus (R = 0.765; p < 0.001) (Fig. 3D). 
 
2.4.Microdialysis studies 
Extracellular concentrations of NE were significantly decreased in response to Mn exposure and ID in the 
caudate putamen versus CN (p < 0.001) (Fig. 4A). In the dialysate samples, Mn concentrations were 
significantly increased in CNMn and IDMn versus CN (p < 0.05) (Fig. 4B). Extracellular concentration of Fe 
was significantly decreased in all dietary treatments versus CN (p < 0.05) (Fig. 4C). A significant correlation 
was observed between extracellularNE and Fe concentrations, with decreased NE associated with decreased Fe 
(R = 0.86; p < 0.001) (Fig. 4C inset). No significant correlation was observed between extracellular NE and Mn 
concentrations. 
 
2.5.Western blot analysis 
Elevated brain Mn and decreased Fe caused an approximate 50% decrease in NET protein expression in the 
globus pallidus, hippocampus, substantia nigra, and locus ceruleus (Fig. 5A). NET protein expression was 
significantly decreased in the globus pallidus (CNMn 33%); ID 59%; IDMn 47%) substantia nigra (CNMn 
73%; IDMn 68%), hippocampus (CNMn 48%; ID 55%; IDMn 36%), and locus coeruleus (IDMn 43%) versus 
CN (p < 0.05) (Fig. 5A). No significant change in NET protein expression was observed in the caudate putamen 
or cerebellum (Fig. 5A). The dietary treatment had no effect on β-actin protein levels. Representative blots for 
NET and β-actin for each region are shown, with each band representing an individual animal (Fig. 5C). 
 
Iron deficiency and Mn exposure were associated with a decrease in protein expression of α2 adrenergic 
receptor in the globus pallidus (CNMn 33%; ID 30%; and IDMn 41%), the substantia nigra (CNMn 55%; ID 
54%; and IDMn 37%), and the locus coeruleus (ID 51%; IDMn 56%) versus CN (p < 0.05) (Fig. 6A). No 
significant change in α2 adrenergic receptor protein expression was observed in the caudate putamen or 
cerebellum (Fig. 6A). The dietary treatment had no effect on β-actin protein levels. Representative blots for α2 
adrenergic receptor and β-actin for each region are shown, with each band representing an individual animal 
(Fig. 6C). 
 
 
2.6.Quantitative PCR analysis 
Increased Mn and ID significantly decreased mRNA expression of NET in the substantia nigra (CNMn 61%; ID 
72%; IDMn 55%; p < 0.05) and cerebellum (CNMn 93%; ID 86%; IDMn 87%; p < 0.05) (Fig. 5B). In the locus 
coeruleus, an increase in mRNA expression of NET was observed in CNMn (130%), while a significant 
decrease was observed in ID (64%) and IDMn (49%) (p < 0.05) (Fig. 5B). Expression of NET mRNA was 
significantly increased in the globus pallidus (CNMn 73%; ID 127%; p < 0.05) (Fig. 5B). No significant change 
in NET mRNA expression was observed in the hippocampus. The dietary treatment had no effect on β-actin 
mRNA levels. 
 
Iron deficiency and Mn exposure were associated with a decrease in mRNA expression of α2 adrenergic 
receptor in the hippocampus (CNMn 63%; ID 57%; IDMn 62%; p<0.05), locus coeruleus (CNMn 61%; ID 
60%; IDMn 61%; p<0.003), and substantia nigra (IDMn 47%; p < 0.05) (Fig. 6B). Iron deficiency was 
associated with a significant decrease in α2 adrenergic receptor mRNA expression in the cerebellum (ID 51%; p 
< 0.05) (Fig. 6B). Expression of α2 adrenergic receptor mRNA was not significantly affected in the caudate 
putamen or globus pallidus. The dietary treatment had no effect on β-actin mRNA levels. 
 
 
3. Discussion 
While previous studies have examined the effects of Mn exposure and ID on DA and GABA biology (Anderson 
et al., 2007; 2008), little research had been conducted to investigate these effects on NE biology. This is the first 
study to date to probe both of these paradigms with regard to the noradrenergic system. Using synaptosomes 
isolated from the caudate putamen and locus coeruleus, a significant correlation was observed between 
synaptosomal Fe concentration and 
3
H-NE uptake after 6 weeks of dietary intervention (Fig. 3), while a 
significant inverse correlation was seen between synaptosomal Mn concentration and 
3
H-NE uptake in 
synaptosomes isolated from the locus ceruleus (Fig. 3). These data demonstrate that Fe and Mn are inversely 
related in terms of neurochemistry (i.e., low Fe and high Mn associated with attenuated NE uptake), with the 
effect being brain region dependent. Exposure to Mn and decreased Fe significantly decreased extracellular 
concentrations of NE in the caudate putamen (Fig. 4A), with a significant correlation observed between 
extracellular concentration of NE and Fe (Fig. 4C inset), but not Mn. In addition, dietary Mn exposure was 
shown to alter expression of NE receptor (Fig. 6) and transport (Fig. 5) proteins and mRNA in vivo, with a 
varied effect observed across the brain regions examined. These data suggest that altered levels of NE due to 
Mn exposure and reduced Fe levels may be the result of changes in expression of transport and receptor proteins 
in the locus coeruleus and basal ganglia, leading to perturbations in extracellular concentrations of NE in the 
caudate putamen. 
 
 
As in earlier studies, our dietary protocol led to an increase in systemic levels of Mn, as evidenced by increased 
plasma Mn concentrations (Fig. 1A). In general, Fe was depleted in those animals receiving the ID diet (Fig. 
2B); however, the only statistical difference in Fe levels in the brain was observed in the globus pallidus, as 
reported before (Anderson et al., 2008) and similar to a previous study from our lab (Erikson et al., 2004). This 
varied response in Fe levels has been observed in our previous studies at both 4 weeks (Anderson et al., 2007) 
and 6 weeks (Anderson et al., 2008; 2007) of dietary exposure, with Fe levels varying between and within 
regions. Further, when the Fe:Mn ratio is examined, a clear reduction in brain Fe in these animals is apparent, 
with the ID diet causing a significant decrease in the Fe:Mn ratio in most regions (Fig. 2C). 
 
Based on our previous studies (Anderson et al., 2008; 2007), we set out to directly examine the effects of Mn 
exposure and ID by measuring 
3
H-NE uptake in synaptosomes. Synaptosomes were chosen due to their 
simplicity and separation from other interacting neuronal systems in order to provide direct interpretation of 
results (Whittaker, 1993). Decreased uptake of 
3
H-NE was observed after 6 weeks of dietary treatment in 
synaptosomes isolated from the caudate putamen and the locus coeruleus, though the effects were region 
dependent (Fig. 3). Conversely, reduced Fe levels were associated with a decrease in 
3
H-NE uptake in the 
caudate putamen and locus coeruleus. This inverse relationship between Mn and Fe has been reported in our 
previous study with regard to 
3
H-GABA uptake (Anderson et al., 2007). The differential response observed in 
the present study may be an effect of time, as these results represent a snapshot of the ongoing neurochemical 
changes occurring over the course of the dietary intervention. For example, in our previous study, 
3
H-GABA 
uptake was affected by Mn exposure and ID differently from four weeks to six weeks of dietary intervention, 
with major effects observed during week six, leading to the premise of the current study examining the effects 
of Mn exposure and ID on NE uptake at 6 weeks. Manganese itself has been shown to affect the uptake of NE 
in a dose-dependent manner in rat forebrain synaptosomes, with selectivity for inhibition of NE uptake versus 
that of DA or GABA (Lai et al., 1982), and in rat whole brain synaptosomes as well (Chandra et al., 1984). 
These effects on uptake of NE in the caudate putamen and locus coeruleus imply altered extra-cellular 
concentrations of NE, which could in turn affect the functioning of the nigrostriatal pathway and behaviors 
associated with the noradrenergic system (Fig. 7). 
 
Extracellular concentrations of NE in the caudate putamen were significantly decreased in response to Mn 
exposure and decreased Fe (Fig. 4A). Extracellular metal concentrations were similar to those observed in our 
previous microdialysis study (Anderson et al., 2008). A correlation between extracellular NE and Fe 
concentrations was also observed, suggesting that lowered Fe levels (due to both dietary deficiency and Mn 
exposure) affect the concentration of extracellular NE. This is not surprising given that Fe is involved in the 
synthesis of norepinephrine through the activity of tyrosine hydroxylase (Beard et al., 1994). Additionally, Fe 
status and brain Mn levels affect brain levels of copper (Cu) (Garcia et al., 2007; Erikson et al., 2004), which 
may adversely impact conversion of dopamine to norepinephrine via the Cu-dependent enzyme dopamine β-
hydroxylase (Pyatskowit and Prohaska, 2007) in the locus coeruleus (Zecca et al., 2004). 
 
With no alterations in protein and mRNA expression of NET observed in the caudate putamen, and given the 
fact that little if any NE is synthesized in this region, these changes in NE concentration are most likely the 
result of alterations in NE biology in the locus coeruleus and the ventral medullary nuclei, major loci of 
adrenergic activity in the brain that play a neuromodulatory role in the caudate putamen and the nigrostriatal 
pathway (Marien et al., 2004). Data supporting direct innervation of the caudate putamen by the locus coeruleus 
is mixed (Berridge and Waterhouse, 2003). Even without direct innervation, NE may affect the caudate 
putamen in a more paracrine fashion via extra-synaptic release from surrounding regions (Marien et al., 2004). 
Still, the involvement of the locus coeruleus in modulating activity of the nigrostriatal pathway is clear. The 
locus coeruleus is important for the facilitation and maintenance of the nigrostriatal dopaminergic pathway, a 
role supported by anatomical, electrophysiological, neuro-chemical, and behavioral studies in animals (see 
review by Marien et al., 2004). This pathway is not only affected in Parkinson's disease, but in manganese 
neurotoxicity as well. Degeneration of the locus coeruleus may precede and potentially surpass dopaminergic 
degeneration in the substantia nigra (Rommelfanger and Weinshenker, 2007), as both regions share anatomical 
and biochemical similarities (Zecca et al., 2004), and depletion of NE in the substantia nigra by greater than 
80% is a hallmark of idiopathic Parkinson disease (Marien et al., 2004), a condition similar to Mn neurotoxicity. 
The attenuated levels of NE observed in the caudate putamen may result from a neuronal loss in the locus 
coeruleus and/or from perturbations in NET and receptor expression, not only in the locus coeruleus but in other 
regions of the basal ganglia, affecting the nigrostriatal pathway and functioning of the caudate putamen (Fig. 7). 
 
ID has been shown to affect both NET (Beard et al., 2006; Burhans et al., 2005) and DAT density and function 
(Erikson et al., 2000; 2001), while Mn exposure and ID alter GAT-1 protein and mRNA expression (Anderson 
et al., 2008). DAT, GAT-1, and NET are all members of the solute carrier-6 (SLC-6) transporter family, sharing 
similar amino acid sequences and pump mechanisms (Gether et al., 2006; Mandela and Ordway, 2006), leading 
to the possibility of similar effects of Mn exposure on NET as those demonstrated with respect to DAT and 
GAT-1. Indeed, NET protein expression was significantly decreased (Fig. 5A), and may result from a decrease 
in mRNA expression in some regions (Fig. 5B). 
 
 
 
While Mn is not known to have specific actions on the transcription of NET, Mn has been shown to bind to 
various forms of DNA structure, leading to conformational changes that might potentially affect the efficiency 
of gene transcription (Hazell et al., 2003; Kennedy and Bryant, 1986). Some shared transcription factors of both 
DAT and NET (Burhans et al., 2005) are influenced by cellular Fe levels, with ID leading to a potential 
decrease in protein expression (Bianco et al., 2008; Ruiz et al., 2000; Kramer- Stickland et al., 1999). Protein 
expression of NET may also be attenuated through post-translational processes, such as recycling and 
degradation, mediated by regulatory kinases that may be affected by excess Mn, a scenario that may be 
occurring in the hippocampus in this instance. Protein kinase C (PKC) is known to regulate NET via 
phosphorylation, causing internalization of these proteins, degradation, and recycling (Mandela and Ordway, 
2006). An acute Mn treatment (300 μM) has been shown to activate caspase-3 leading to activation of PKCδ in 
N27 mesenchephalic cells (Latchoumycandane et al., 2005). A similar response was seen in those cells 
incubated for 72 h with a lower dose of Mn (50 μM), replicating chronic exposure. This 300 μM dose represents 
a physiologically relevant dose similar to that achieved in the current study. Also, increased expression of PKC-
β1 has been reported in the caudate putamen during ID (Bianco et al., 2008), indicating further potential for 
PKC signal transduction. Decreases in both mRNA and protein expression of NET might indicate neuronal loss 
as a result of Mn exposure (Sloot et al., 1994), via caspase -mediated apoptosis (Latchou-mycandane et al., 
2005). In addition, necrotic neuronal loss may be occurring through a caspase-independent pathway as well 
(Roth et al., 2000). 
 
An increase in NET mRNA was observed in the globus pallidus in response to Mn exposure and the ID diet 
(Fig. 5B). This increase in NET mRNA in the globus pallidus may be a compensatory mechanism in response to 
the decrease seen in NET protein expression in that region. In the locus coeruleus, a varied effect of Mn 
exposure and ID on NET mRNA expression was observed, with an increase in CNMn animals and a decrease in 
ID and IDMn animals (Fig. 5B). This varied response is most likely indicative of a region in which a variety of 
mechanisms are occurring simultaneously, such as compensation for NET protein loss through degradation 
pathways, effects on gene transcription, and/or neuronal loss. Action of NE at pre-synaptic α2 adrenergic 
receptors, which regulate NE activity and NET expression (Marien et al., 2004), may also be involved in this 
region, and the others examined. 
 
Expression of NET may be affected by the action of pre-synaptic autoreceptors, which can play a part in 
regulating expression of the protein (Mandela and Ordway, 2006; Zahniser and Doolen, 2001). Decreases in 
these autoreceptors (specifically α2 adrenergic receptor) could result in a general decrease of NET density in 
that region. As anticipated, α2 adrenergic receptor protein and mRNA expression were decreased (Figs. 6A and 
B) in regions in which NET protein expression was also lowered (Fig. 5A). These losses in α2 adrenergic 
receptor expression would lead to dysregulation of the noradrenergic system in the locus coeruleus and 
alterations in NE synthesis and release (Marien et al., 2004). Lesions of the locus coeruleus and chronic 
attenuated levels of NE have been shown to affect DA concentrations in the caudate putamen using knockout 
mouse models of the α2 adrenergic receptor (Marien et al., 2004). Dysfunction of the adrenergic system in the 
locus coeruleus could further exacerbate the dysregulation of the nigrostriatal pathway observed during Mn 
neurotoxicity, leading to perturbations in motor activity (Fig. 7). 
 
In conclusion, the alterations observed in protein and mRNA expression of NE receptor (Fig. 6) and transport 
proteins (Fig. 5) were not universal, with a diverse effect of Mn exposure and ID-associated Mn accumulation 
on these two indices not only from region to region, but, in some cases, within the same region (such as the 
locus coeruleus), consistent with the effects on the GABAergic system that we have previously reported 
(Anderson et al., 2008; 2007). The alterations in NE biology observed in this study, including attenuated uptake 
(Fig. 3), reductions in extracellular concentrations (Fig. 4), and effects on NE transporter (Fig. 5) and receptor 
(Fig. 6) protein and gene expression, could have profound effects on the functioning of the locus coeruleus 
causing dysregulation of the nigrostriatal pathway leading to behavioral alterations such as reduced motor 
activity, impaired cognition, and increased anxiety (Meyer and Quenzer, 2005; Beard et al., 2006). Furthermore, 
the novel results of this study illustrate the complex mechanisms at play during Mn neurotoxicity and ID. 
Whether our findings in this study are due to either Mn exposure or ID alone is difficult to say, given that these 
two pathologies may be concurrent. When examining these data in conjunction with our previous studies 
(Erikson et al., 2002; Anderson et al., 2008; 2007), it is clear that the neurobiological changes that are related to 
extracellular neurotransmitter concentrations are due to the lowered Fe levels (Fig. 4C; Anderson et al., 2008), 
whereas those changes related to tissue neurotransmitter biology are due to increased Mn levels in our current 
experimental model (Fig. 3C; Erikson et al., 2002; Anderson et al., 2007; 2008). It is also quite possible that 
increased Mn and decreased Fe levels due to Mn exposure and ID may be affecting concentrations of other 
metals, particularly Cu (Garcia et al., 2007) which would have a significant impact on NE biology (Pyatskowit 
and Prohaska, 2007). Thus, future studies that tease apart the effects of the alterations of these metals on 
neurochemical functioning are critical in order to develop effective modalities not only for the treatment of 
vulnerable populations (e.g., Mn-exposed workers, ID individuals), but also for understanding the etiology of 
neurodegenerative diseases where brain metal imbalances are implicated (e.g., Parkinson's disease, Huntington's 
disease, Alzheimer's disease). 
 
4. Experimental procedures 
4.1. Animals 
Male weanling Sprague–Dawley rats (Harlan Sprague–Dawley, Indianapolis, IN) (n=48 for synaptosome 
studies; n=24 for microdialysis studies; n=24 for Western and PCR analysis) were randomly divided into four 
dietary treatment groups as in previous studies (Anderson et al., 2008; 2007): control (CN; 35 mg Fe/kg, 10 mg 
Mn/kg diet and d.i. water); control Mn-exposed (CNMn; control diet and 1 g Mn (as MnCl2)/L d.i. water); iron-
deficient (ID; 4 mg Fe/kg, 10 mg Mn/kg diet and d.i. water); and iron-deficient/Mn-exposed (IDMn; ID diet and 
1 g Mn/L d.i. water). Diets were obtained from Bio-Serv (Frenchtown, NJ) and certified for metal content. Rats 
had free access to food and water 24 h/day, with the lights off between 1800 and 600 h and room temperature 
maintained at 25±1 °C. The University of North Carolina at Greensboro Animal Care and Use Committee 
approved all of the animal procedures. 
 
 
4.2. In vitro studies 
Synaptosomes were utilized to indirectly assess the effect of ID and Mn exposure on disturbances in NE 
biology by measuring3H-NE uptake, following our previously described (Anderson et al., 2007) modified 
method from Cotman et al. (1981). After 6 weeks of dietary treatment, brain regions (caudate putamen and 
locus coeruleus) from two rats per treatment group were pooled for each individual experiment. Briefly, tissue 
was homogenized using a Teflon/glass homogenizer in 20 volumes of ice-cold 0.32 M sucrose–HEPES, pH 7.4.  
The homogenate was then centrifuged at 2000×g for 10 min at 4 °C. The supernatant was removed and 
centrifuged at 20,000×g for 15 min at 4 °C. The pellet was resuspended in 10 mL fresh ice cold Krebs–Ringer–
HEPES (KRH) buffer [118.4mM NaCl, 1.18 mM MgSO4, 4.7 mM KCl, 1.2 mM KH2PO4, 10.0 mM HEPES, 
5.6 mM dextrose (pH 7.4)]. An aliquot of 200 μL of the synaptosomes was placed in a tube with 50 μL KRH 
buffer. A 10 μL aliquot of 
3
H-NE (50 nM at a specific activity of 10.9 Ci/mmol) (NEN, Boston, MA) was added 
to each tube and tubes were incubated for 15 min at 37 °C. The reaction was stopped by adding 5 mL ice-cold 
KRH buffer to each tube, followed by rapid filtration through a GF/F Whatman fiberglass filter on a Millipore 
sampling manifold. Filters were washed twice with ice cold KRH, placed in scintillation vials with 5 mL 
scintillation cocktail, and counted on a Beckman LS scintillation counter (Beckman, Fullerton, CA). An 
additional set of tubes, one for each treatment group, was incubated on ice (approximately 4 °C) to determine 
non-specific uptake. Protein analysis was performed utilizing the bicinchoninic acid (BCA) method (Pierce, 
Rockford, IL) to determine total protein of the synaptosome fraction. 
 
4.3.Stereotaxic surgery 
After 5 weeks of dietary treatment and 1 week prior to micro-dialysis experiments, rats were anesthetized with 
ketamine–HCl (80 mg/kg) and xylazine (12 mg/kg) (IDMn dosage: ketamine–HCl 60 mg/kg; xylazine 8 mg/kg) 
and maintained on a heating pad at 37 °C. The heads of the rats were shaved and wiped with a 5% povidone–
iodine solution to reduce risk of infection. Sterile instruments and gloves were used throughout the surgical 
procedure. The rats were secured in the stereotaxic frame and an incision was made perpendicular to the 
bregma. A guide cannula (CMA/12, CMA Microdialysis, Acton, MA) was implanted into the caudate putamen 
using the following coordinates: 2.4 mm lateral to the midline, 7.5 mm anterior to the lambda. The cannula was 
lowered to a depth of 2.5 mm, positioning it in the medial area of the caudate putamen (Paxinos and Watson, 
1998). 
 
Anchoring screws were utilized to maintain the position of the cannula before being cemented into place using 
dental adhesive. Animals were given 0.9% sterile saline (0.5 mL/kg body weight, i.p.) to reduce the fluid lost 
while under anesthesia and to aid in recovery time. Animals were also given the xylazine reversal agent 
Antisedan (Atapimazole) (0.1 mg/kg body weight, i.p.) (Allivet, Hialeah, FL), to reduce recovery time. Animals 
were returned to shoebox cages with Tek-Fresh bedding (Harlan, Indianapolis, IN) and monitored daily until 
microdialysis experiments began. 
 
4.4.Microdialysis 
During week six of the dietary protocol, a microdialysis probe (CMA/12 Elite, CMA Microdialysis, Acton, 
MA) was inserted into the guide cannula and the rat was perfused with artificial cerebral spinal fluid (aCSF) 
(155 mM Na
+
, 0.83 mM Mg
2+
, 2.9 mM K
+
, 132.76 mM Cl
-
, 1.1 mM Ca
+
, pH 7.4) for 1 h at a flow rate of 1 μL/ 
min. After perfusion, the flow rate was adjusted to 0.5 μL/min and 30 minute fractions were collected in 
microtubes for a total of four and a half hours (9 samples per rat) in a refrigerated fraction collector (CMA 
Microdialysis, Acton MA). Samples were stored at -80 °C until analysis of the dialysate fraction. To quantify 
levels of NE from the microdialysate, fractions were analyzed using capillary electrophoresis with laser induced 
fluorescence detection (CE-LIF) (Biorad Biofocus 2000, Hercules, CA, with 488 nm diode laser/590 nm 
emission filter). Rats were then returned to their home cage, and on the following day were sacrificed, brains 
removed, and probe placement verified post mortem. Brains were dissected into six regions (caudate putamen, 
globus pallidus, substantia nigra, hippocampus, locus coeruleus, and cerebellum) for metal, protein, and mRNA 
analyses (see below). The same individual dissected all brain regions, using brain atlas coordinates (Paxinos and 
Watson, 1998) and a stainless steel rat brain matrix for coronal sectioning. Regions were selected based on the 
known heterogeneous accumulation of metals in response to alterations in dietary Fe and Mn levels (Anderson 
et al., 2008; 2007; Erikson et al., 2002) and the density of adrenergic neurons. 
 
4.5.CE-LIF analysis 
A protocol by Chen et al. (2001) allowing for detection of amino acids and biogenic amines at nanomolar 
concentrations modified to accommodate the needs of our previous study (Anderson et al., 2008) was utilized in 
the current study as well. The advantages of applying CE analysis to neuroactive compounds include minimal 
required sample volumes, speed of analysis, and high separation efficiency (Powell and Ewing, 2005). Briefly, 
on the day of sample analysis, 5 μL of microdialysate sample were derivatized at 40 °C by the addition to 100 
nmol ATTO-TAGTm FQ fluorogenic reagent (Molecular Probes, Eugene, OR) and 10 μL of a 10 mM borate 
(Fisher, Fair Lawn, NJ)/25 mM KCN (Fluka) solution (pH 9.18). The total sample volume was adjusted to 20 
μL using HPLC grade methanol (G.J. Chemical Company, Newark, NJ). After a minimum reaction time of 90 
min, 1 μL of an FQ derivatized homoserine (Sigma, St.Louis, MO) internal standard solution was added to the 
derivatized microdialysate sample and analyzed. CE-LIF conditions leading to high efficiency peaks for NE 
samples were 10 kV for 10 min with sample injections at 10 psi/s. Uncoated silica capillary (Polymicro, 
Arizona) with an i.d. of 25 μm, o.d. of 361 μm, and effective/total lengths of 25.4/30.0 cm was used. The run 
buffer was 15 mM sodium borate (Fisher), pH 9.0, with 45 mM sodium dodecyl sulfate (Pierce, Rockford, IL), 
5 mM sodium cholate (Anatrace, Maumee, OH), and 4% (v/v) 2-propanol (Fisher). Three replicates were 
analyzed for each sample, with a calibration curve for NE constructed each day of sample analysis using three 
points with a concentration range of 5 μM to 10 μM NE. Noreinephrine (Sigma) and homoserine standard 
solutions used for construction of calibration curves were prepared in aCSF with the same composition as that 
used in the microdialysis studies. To verify that NE content in microdialysate samples fell within the sensitivity 
range of the method, a calibration curve was constructed by serial dilution of derivatized standards until such 
time as no discernable peak was obtained for NE. From this, the limit of detection for NE, de-fined as 3σ/m, 
where σ represents the standard deviation of the background and m represents the slope or sensitivity of the 
calibration curve, was determined to be 59 nM for this method, with a linear dynamic range of 2.93 decades. 
The ratio of NE peak height to homoserine peak height for each sample was used to determine the concentration 
of NE based on the calibration curve response. 
 
4.6.Protein extraction 
Protein was extracted from the brain tissue samples for Western blot analysis. Tissue samples were sonicated in 
500 μL of RIPA lysis buffer (1% Nonidet 40, 1% SDS, 0.5% sodium deoxycholate, 1 mM NaF, 2 mM β-
glycerolphosphate, 1 mM sodium orthovanadate, and 1× protease inhibitor cocktail (Sigma, St. Louis, MO) in 
1× PBS) on ice until completely homogenized. Homogenates were incubated on ice for 20 min before being 
centrifuged at 10,000×g for 20 min at 4 °C. Supernatant was then transferred to new tubes and the total protein 
concentration was determined by BCA assay (Pierce, Rockford, IL) before proceeding with Western analysis. 
 
4.7.Western blot analysis 
Western blot analysis was conducted to examine the effects of the dietary treatment on expression of NET and 
α2 adrenergic receptor in vivo. The α2 adrenergic receptor was chosen due to its role in regulating adrenergic 
activity and expression of NET (Marien et al., 2004). Protein samples (20 μg) were combined with 4× LDS 
sample buffer (Invitrogen, Carlsbad, CA) containing 5% β-mercaptoethanol and heated at 70 °C in a heat block 
for 10 min. Samples were then loaded onto a 4-12% Bis-Tris pre-cast mini gel (Invitrogen, Carlsbad, CA) and 
electrophoretically separated under denaturing conditions in 1× MOPS buffer containing 1% antioxidant 
(Invitrogen, Carlsbad, CA). Proteins were transferred to a PVDF membrane (Millipore, Billerica, MA) before 
blocking with 5% BSA. Membranes were probed overnight at 4 °C with primary antibody (rabbit polyclonal 
anti-NET; rabbit polyclonal anti-α2 adrenergic receptor; Chemicon, Temecula, CA) (mouse monoclonal anti-β-
actin; Santa Cruz Biotech, Santa Cruz, CA) for the protein of interest in 5% BSA. Membranes were rinsed in 1× 
TBST (10 mM Tris, pH 7.4, 150 mM NaCl, 0.05% Tween 20) and probed for 2 h at room temperature with an 
HRP-conjugated secondary antibody (goat anti-rabbit; Chemicon, Temecula, CA) (goat anti-mouse; Santa Cruz 
Biotech, Santa Cruz, CA) in 5% BSA. Membranes were then rinsed several times in 1× TBST before incubation 
in ECL solution (Perkin Elmer, Waltham, MA) and exposure to radiographic film (Pierce, Rockford, IL). 
Membranes were probed for β-actin to verify equal loading and for image analysis. This housekeeping protein 
was chosen for comparison over GAPDH, which has been shown to be affected by Mn concentrations (Hazell, 
2002). Films were analyzed using image analysis software (Image J, NIH, Bethesda, MD), with the amount of 
the target protein from each sample standardized to the amount of β-actin from the same sample. 
 
4.8.RNA isolation and cDNA synthesis 
Total RNA was isolated from brain regions for quantitative PCR analysis. Tissue samples were stored in 1 mL 
of RNAlater® solution (Ambion Inc., Austin, TX) and stored at -20 °C until analysis. Total RNA was isolated 
utilizing the ToTALLY RNATm kit (Ambion Inc., Austin, TX) following the manufacturer's instructions. RNA 
concentration and purity were determined by spectrophotometric analysis before carrying out cDNA synthesis. 
Synthesis of cDNA from total RNA was performed using the High Capacity cDNA Reverse Transcriptase Kit 
(Applied Biosystems, Foster City, CA) following the manufacturer's instructions. 
 
4.9.Quantitative PCR 
Quantitative real-time PCR analysis was utilized to deter-mine the effects of the dietary protocol on the mRNA 
expression of NET and α2 adrenergic receptor. Triplicate aliquots of cDNA were analyzed on 96-well plates 
using expression assays for the genes of interest obtained from Applied Biosystems (Foster City, CA). Values 
of cDNA expression were normalized relative to the expression of β-actin analyzed from the same sample on 
the same plate and reported as percent of control. 
 
4.10. Metal analysis 
Tissue Mn and Fe concentrations were measured with graphite furnace atomic absorption spectrometry (Varian 
AA240, Varian, Inc., USA). Blood samples were collected at the end of the experiment into heparinized tubes, 
cooled to 4 °C, and centrifuged for 15 min to separate cells from plasma. Plasma was frozen at - 80 °C until 
analyzed for Mn and Fe. Equal volumes of plasma and 0.5% Triton-X were vortexed for 30 s before being 
centrifuged at 12,000×g for 10 min. The supernatant was removed and an aliquot of 50 μL was brought to 1 mL 
total volume in 2% nitric acid and analyzed for Mn and Fe content. Brain regions (caudate putamen, globus 
pallidus, substantia nigra, hippocampus, locus coeruleus, and cerebellum) were digested in ultra-pure nitric acid 
(1:10 w/v dilution) for 48–72 h in a sand bath (60 °C). A 50 μL aliquot of digested tissue was brought to 1 mL 
total volume with 2% nitric acid for analysis. The unused fraction of synaptosomes from each dietary treatment 
was centrifuged at 2000×g for 10 min at 4 °C. The supernatant was removed and the pellet was digested in 500 
μL ultra-pure nitric acid for 48 h. A 100 μL aliquot was brought up to 1 mL total volume with 2% nitric acid for 
analysis. Bovine liver (NBS Standard Reference Material, USDC, Washington, DC) (10 μg Mn/g; 184 μg Fe/g) 
was digested in ultra-pure nitric acid and used as an internal standard for analysis (final concentration 5 μg Mn/ 
L; 92 μg Fe/L). 
 
4.11. Statistical analysis 
Statistical analyses were conducted using SPSS v14. Data were examined for normality of distribution using a 
one-sample Kolmogorov–Smirnov test and for the presence of outliers by boxplot analysis. Data were analyzed 
using analysis of variance, with Dunnett's post-hoc analysis conducted to assess difference from controls when 
p<0.05.Pearson's correlational analyses were conducted to examine relationships between: 1) 
3
H-NE uptake and 
Mn/Fe concentrations; and 2) extracellular concentrations of NE, Mn, and Fe. 
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